Claus Runge

Claus Runge leads the public affairs, sustainability and internal engagement group at Bayer AG's Pharmaceuticals Division and acts as its chief health equity officer. Claus has 25 years of experience working in the pharmaceutical industry. He has held senior roles on both local and global levels in various multinational companies, such as GSK, Wyeth, and AstraZeneca. In his career, he has been responsible for a broad span of functions, including commercial, pricing, and market access; communications; governmental affairs; and patient advocacy. Claus is a pharmacist and health economist by training and holds a Ph.D. from Humboldt University in Berlin.

Latest Articles

There’s a $660 billion economic opportunity in reproductive health

about 1 month ago // Sponsored by FP2030

Opinion: Bridging the $14B family planning gap requires more than just funding — it takes innovation and cross-sector grit. By scaling digital health and public-private alliances, we can unlock a $660B dividend for humanity.

Opinion: Upholding women’s rights and choices during a pandemic

over 4 years ago // Sponsored by Bayer

Bayer and UNFPA partnership reflect on the role of innovation and agility in maternal health during the COVID-19 pandemic.

Opinion: The power of choice — ensuring access to family planning in the COVID-19 era

over 5 years ago // Produced in Partnership: Bayer

The COVID-19 pandemic is already disrupting sexual and reproductive health and rights globally. Representatives from Bayer and UNFPA highlight the need to ensure access to contraceptives both during and after the pandemic — or else risk devastating consequences for many women.

See all articles by Claus Runge